PMC:7321036 / 4464-4739
Annnotations
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T119 | 33-43 | DG_28 | denotes | remdesivir |
| T120 | 74-82 | SP_7 | denotes | COVID-19 |
| T121 | 137-147 | SP_7 | denotes | SARS-CoV-2 |
| T122 | 160-166 | CHEBI:52217;CHEBI:52217 | denotes | agents |
| T123 | 257-265 | SP_7 | denotes | COVID-19 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T43 | 74-82 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T44 | 137-145 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T45 | 257-265 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T19 | 33-43 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 116 | 51-59 | Species | denotes | patients | Tax:9606 |
| 117 | 137-147 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 118 | 211-221 | Species | denotes | outpatient | Tax:9606 |
| 120 | 33-43 | Chemical | denotes | remdesivir | MESH:C000606551 |
| 126 | 74-82 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 127 | 257-265 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T30 | 0-275 | Sentence | denotes | Although the evidence supporting remdesivir use in patients with advanced COVID-19 is promising, there remains an urgent need for potent SARS-CoV-2 therapeutic agents, especially those that could be given in an outpatient setting, to effectively combat the COVID-19 pandemic. |